News

Solis Mammography Welcomes Industry Leader Lisa Ashby as CEO

Solis Mammography Welcomes Industry Leader Lisa Ashby as CEO

Solis Mammography Welcomes Industry Leader Lisa Ashby as CEO

Proven Healthcare Executive to Lead Company's Continued Growth and Expansion in Women's Diagnostic Health

Solis Mammography, the nation's largest independent provider of specialized breast health services, has announced a significant leadership change with the appointment of Lisa Ashby as Chief Executive Officer. This decision marks a pivotal moment for the organization as Ashby takes over the reins from Grant Davies, who is stepping down after six years of dedicated service.

Lisa Ashby: A Visionary Leader

Ashby brings an impressive three-decade track record in healthcare leadership, characterized by her ability to drive growth and execute disciplined strategies aimed at enhancing patient outcomes. Her most recent role as CEO of Carestream Dental saw her spearheading a multi-year transformation, reorienting the company to a digital and patient-first model, while also achieving substantial operational efficiencies and fostering product innovation.

Transforming Healthcare with Innovation

In her transformative role at Carestream, Ashby directed the organization towards embracing advanced imaging technologies and AI-enhanced software, significantly improving digital workflows for healthcare providers and patients. Prior to this, she accumulated over 25 years at Cardinal Health, where she held senior leadership positions, including that of President of Medical Devices and Diagnostics, overseeing a global portfolio valued at $3 billion across multiple companies.

Focus on Growth and Patient Experience

With Ashby at the helm, Solis is poised to continue its commitment to enhancing the patient experience and strengthening clinical partnerships. The organization remains dedicated to its national growth strategy while thoughtfully expanding its array of services. Solis is driven by the principle that women deserve an elevated standard of diagnostic care and aims to improve access to vital preventive healthcare services.

“Lisa is a proven leader with a sophisticated understanding of how to scale complex healthcare organizations, and we’re thrilled to welcome her to Solis,” noted Davies. “As Solis continues to expand its core mammography business into a comprehensive women’s diagnostic health platform, Lisa’s extensive experience in operational excellence and mission-driven growth will serve us well.”

A Commitment to Women’s Health

Ashby expressed her enthusiasm about her new role, stating, “Solis has established an outstanding reputation for clinical excellence and patient-focused care. I am honored to join the company at such a critical juncture in its growth.” She looks forward to leveraging her experience to broaden Solis’ preventive and diagnostic healthcare solutions for women and to elevate the organization’s service within health systems and among physician partners. “Achieving this vision will require collaboration, and I am eager to work alongside the Board and the talented Solis team to build upon the strong foundation already in place,” she added.

About Solis Mammography

Solis Mammography has been at the forefront of women’s health for 40 years, dedicated to the early detection of breast cancer. Operating over 160 centers across key markets, the organization provides specialized breast health services. Positioned as a leading provider in women’s health, Solis Mammography continues to focus on pioneering a retail healthcare experience that embodies a commitment to clinical excellence. This includes operating both wholly-owned centers and thriving joint ventures with major hospital systems and prestigious medical institutions.

Frequently Asked Questions

Who is the new CEO of Solis Mammography?

Lisa Ashby has been appointed as the new CEO of Solis Mammography, succeeding Grant Davies.

What experience does Lisa Ashby bring to the role?

Ashby has over 30 years of experience in healthcare leadership, including strategic roles at Carestream Dental and Cardinal Health.

What are Solis Mammography's commitments under Ashby's leadership?

Under Ashby, Solis will focus on enhancing patient experience, strengthening clinical partnerships, and expanding service lines.

How has Solis Mammography impacted women's health?

Solis Mammography has been dedicated to early detection of breast cancer and providing specialized services for women for 40 years.

What is the future vision for Solis Mammography?

The vision includes expanding preventive and diagnostic healthcare solutions for women while maintaining a strong focus on clinical excellence.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Key Dates for AB Akola Group Investors in 2025

Updated Category News Views 224

Important Milestones for AB Akola Group Investors in 2025 Understanding the critical dates for investors is essential in navigating the financial landscape. AB Akola Group has outlined key disclosure dates for the year 2025, which will serve as pivotal moments for shareholders and potential investors alike. February Releases: Unaudited Financial Reports In February, the...

Continue Reading
ValOre's Exploration Update Shows Promising PGE Results

Updated Category News Views 87

ValOre’s Latest Exploration Progress at Salvador ValOre Metals Corp. has shared new results from the Salvador target within the Pedra Branca Platinum Group Elements (PGE) Project. Early work—Trado® auger drilling paired with rock sampling—has confirmed in-situ PGE mineralization. It’s a clear step forward in understanding what’s driving the system at Salvador...

Continue Reading
Aerospacelab Expands U.S. Operations with New Facility Opening

Updated Category News Views 73

Aerospacelab Expands Operations in the U.S. Aerospacelab, Inc. has proudly opened its new satellite manufacturing facility, a strategic move that places the company in the heart of the booming aerospace industry and responds to the growing demand for satellite technology. Overview of the New Manufacturing Facility This state-of-the-art facility spans 35,000 square feet,...

Continue Reading
Exciting New Housing Project for Seniors to Enhance Community Living

Updated Category News Views 241

Introduction to Lighthouse Villa Canada faces a significant challenge in providing affordable housing, particularly for its senior citizens. In a move to address these urgent needs, funding has been announced for Lighthouse Villa, an innovative housing project that aims to enhance the living conditions of independent seniors. Project Overview Lighthouse Villa, located at...

Continue Reading
Investors Rally for Justice in Aehr Test Systems Case

Updated Category News Views 135

Investors Rally for Justice in Aehr Test Systems Case Aehr Test Systems (NASDAQ: AEHR) is currently facing a significant securities fraud lawsuit that has captured the attention of investors and legal experts alike. The law firm of Rosen is spearheading this movement and reminding all purchasers of Aehr securities that they may have an opportunity to take action....

Continue Reading